BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23114739)

  • 1. Pneumococcal vaccine for adults.
    Med Lett Drugs Ther; 2012 Oct; 54(1402):87-8. PubMed ID: 23114739
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter from the Editor: pneumococcal conjugate vaccine.
    Ellis R
    Hum Vaccin Immunother; 2014; 10(9):2754. PubMed ID: 25483629
    [No Abstract]   [Full Text] [Related]  

  • 3. A 10-valent conjugate vaccine for some countries.
    Prescrire Int; 2011 Jan; 20(112):8. PubMed ID: 21462783
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults.
    Peñaranda M; Payeras A; Cambra A; Mila J; Riera M;
    AIDS; 2010 May; 24(8):1226-8. PubMed ID: 20299956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
    Long SS
    Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?
    Musher DM; Sampath R; Rodriguez-Barradas MC
    Clin Infect Dis; 2011 Mar; 52(5):633-40. PubMed ID: 21292668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance.
    Vergison A; Hanquet G
    Pediatr Infect Dis J; 2012 Apr; 31(4):400-3. PubMed ID: 22418653
    [No Abstract]   [Full Text] [Related]  

  • 9. Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccination.
    Barzilay EJ; O'Brien KL; Kwok YS; Hoekstra RM; Zell ER; Reid R; Santosham M; Whitney CG; Feikin DR
    Vaccine; 2006 Feb; 24(7):904-13. PubMed ID: 16203059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine.
    Ray GT
    Expert Rev Vaccines; 2002 Jun; 1(1):65-74. PubMed ID: 12908513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of pneumococcal conjugate vaccines to public health: Thailand perspective.
    Wongsawat J; Chokephaibulkit K
    J Med Assoc Thai; 2010 Nov; 93 Suppl 5():S53-60. PubMed ID: 21294383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal vaccines in adults: assessing the evolving evidence.
    Grabenstein JD; Manoff SB
    Vaccine; 2011 Aug; 29(37):6149-54. PubMed ID: 21763386
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome.
    Liakou CD; Askiti V; Mitsioni A; Stefanidis CJ; Theodoridou MC; Spoulou VI
    Vaccine; 2011 Sep; 29(40):6834-7. PubMed ID: 21803106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.
    Miiro G; Kayhty H; Watera C; Tolmie H; Whitworth JA; Gilks CF; French N
    J Infect Dis; 2005 Nov; 192(10):1801-5. PubMed ID: 16235180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.
    Tam JC; Grant NL; Freire-Moran L; Tolmie H; French N; Gordon SB
    J Allergy Clin Immunol; 2009 Jun; 123(6):1420-1. PubMed ID: 19423153
    [No Abstract]   [Full Text] [Related]  

  • 16. 13-valent pneumococcal conjugate vaccine.
    Prescrire Int; 2011 Jan; 20(112):5-7, 9. PubMed ID: 21462782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine.
    Gadzinowski J; Albrecht P; Hasiec B; Konior R; Dziduch J; Witor A; Mellelieu T; Tansey SP; Jones T; Sarkozy D; Emini EA; Gruber WC; Scott DA
    Vaccine; 2011 Apr; 29(16):2947-55. PubMed ID: 21335032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal conjugate vaccine, polysaccharide vaccine, or both for adults? We're not there yet.
    O'Brien KL
    Clin Infect Dis; 2009 Nov; 49(9):1326-8. PubMed ID: 19814622
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for other neonatal infections: pneumococcal disease: a major global health problem of young children.
    Richmond P
    Expert Rev Vaccines; 2004 Aug; 3(4):379-82. PubMed ID: 15270639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.